The United Laboratories International Holdings Limited Schedules Board Meeting to Approve 2025 Annual Results and Consider Dividend

Key Highlights for Investors:

• Board Meeting Date Set: The Board of Directors of The United Laboratories International Holdings Limited (Stock Code: 3933) has scheduled a key meeting on Tuesday, 24 March 2026.
• 2025 Annual Results Approval: At this meeting, the Board will consider and approve the annual results for the financial year ended 31 December 2025. The release of annual results is a significant event for investors, as it provides a comprehensive update on the company’s financial performance, profitability, and overall business health.
• Final Dividend Recommendation: The Board will also discuss and may recommend the payment of a final dividend. Any decision regarding dividends is crucial and price-sensitive information, as it directly affects shareholders’ returns and can influence market sentiment and the company’s share price.

Details for Shareholders:

• The announcement is a formal notification to the market, ensuring transparency and compliance with disclosure obligations.
• Shareholders and potential investors should pay close attention to the outcome of the Board meeting, as both the announcement of annual results and any dividend declaration are considered price-sensitive events that could impact the company’s share valuation.
• Investors are advised to monitor further announcements from the company on or after the scheduled Board meeting date, as these will contain the finalized results and any decisions on the dividend.

Board Composition:

• The Board consists of a mix of executive and independent non-executive directors, ensuring a broad perspective in decision-making. Key board members include Mr. Tsoi Hoi Shan, Mr. Leung Wing Hon, Ms. Choy Siu Chit, Mr. Fang Yu Ping, Ms. Zou Xian Hong, Ms. Zhu Su Yan (executive directors), and Mr. Chong Peng Oon, Prof. Song Ming, and Dr. Fu Qiushi (independent non-executive directors).

Potential Impact on Share Price:

The confirmation of the Board meeting to approve annual results and consider a final dividend is a material event. The actual financial performance and any dividend payout announced following this meeting may significantly influence investor sentiment and the market value of the company’s shares.

Disclaimer: The information above is based on a company announcement and is intended for informational purposes only. Investors are advised to exercise caution and await the final results and dividend declaration before making investment decisions. The company and the Hong Kong Stock Exchange accept no responsibility for the content or accuracy of this summary.

View UNITED LAB Historical chart here